A GRA2 minimal promoter improves the efficiency of TATi / Tet-Off conditional regulation of gene expression in Toxoplasma gondii.


Journal

Molecular and biochemical parasitology
ISSN: 1872-9428
Titre abrégé: Mol Biochem Parasitol
Pays: Netherlands
ID NLM: 8006324

Informations de publication

Date de publication:
07 2021
Historique:
received: 22 03 2021
revised: 23 05 2021
accepted: 24 05 2021
pubmed: 30 5 2021
medline: 2 9 2021
entrez: 29 5 2021
Statut: ppublish

Résumé

A tetracycline-responsive transcription system (Tet-Off) adapted for use in Toxoplasma gondii (nicknamed TATi) is useful for molecular biological studies of this organism. Previous studies using TATi incorporated minimal promoters derived from the gene promoters for TgSAG1 or TgSAG4. The present study achieves improved activation and suppression of an integrated reporter gene in the absence and presence of anhydrotetracycline, respectively (p < 0.0001), by use of a newly derived minimal promoter based on the core promoter of TgGRA2. In comparison with the SAG1 minimal promoter, use of the GRA2 minimal promoter in stable transfectants has a 23-fold higher Signal to Noise Ratio for EYFP fluorescence in the absence or presence of anhydrotetracycline. We conclude that the performance of TATi for both activation and suppression of transcription can be markedly enhanced by incorporating a GRA2 minimal promoter.

Identifiants

pubmed: 34051228
pii: S0166-6851(21)00035-9
doi: 10.1016/j.molbiopara.2021.111384
pii:
doi:

Substances chimiques

Antigens, Protozoan 0
Bacterial Proteins 0
Gra2 protein, Toxoplasma gondii 0
Luminescent Proteins 0
Membrane Glycoproteins 0
Protozoan Proteins 0
Recombinant Proteins 0
SAG1 antigen, Toxoplasma 0
SAG4 protein, Toxoplasma gondii 0
Tetracyclines 0
yellow fluorescent protein, Bacteria 0
4-epianhydrotetracycline 680VDL31MX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111384

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Mohammad Farouq Sharifpour (MF)

School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, South Australia, Australia.

Shadi Khadiv (S)

School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, South Australia, Australia.

Markus Meissner (M)

Institute for Experimental Parasitology, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität Munich, Bavaria, Germany.

Milton M McAllister (MM)

School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, South Australia, Australia. Electronic address: milton.mcallister@adelaide.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH